A STUDY OF THE ADRENOTROPIC RECEPTORS

1948/06/01 by Raymond P. Ahlquist · 34 citations
Chemistry · Engineering · Medicine · #Adipose Tissue and Metabolism #Chemistry #Electrochemical sensors and biosensors #Heart Rate Variability and Autonomic Control #Internal medicine #Medicine #Physiology #Receptor

paper · doi:10.1152/ajplegacy.1948.153.3.586

openalex publication_date 1948/06/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/08/04

Cited by

• Distributions of mRNAs for alpha‐2 adrenergic receptor subtypes in rat brain: An in situ hybridization study
• Activation of vascular smooth muscle of rat aorta by noradrenaline and depolarization: Two different mechanisms
• On chiral drug action
• The Receptor Concept: A Continuing Evolution
• Beta-blockers in anxiety disorders
• One hundred years of adrenaline: the discovery of autoreceptors
• The emergence of the drug receptor theory
• Genetic mapping of adrenergic receptor genes in humans
• History of catecholamine research [wikipedia]
• Current and future status of beta-blockers in the treatment of hypertension. [europepmc]
• Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5. [europepmc]
• Attenuation of beta2-adrenergic receptors and homocysteine metabolic enzymes cause diabetic cardiomyopathy. [europepmc]
• Cardiac and neuroprotection regulated by α(1)-adrenergic receptor subtypes. [europepmc]
• Phaeochromocytoma: a catecholamine and oxidative stress disorder. [europepmc]
• G-protein-coupled receptors in adult neurogenesis. [europepmc]
• GPCRs and arrestins in airways: implications for asthma. [europepmc]
• Bronchoprotection and bronchorelaxation in asthma: New targets, and new ways to target the old ones. [europepmc]
• β 2 Agonists. [europepmc]
• Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon. [europepmc]
• Homeostatic systems, biocybernetics, and autonomic neuroscience. [europepmc]
• Noradrenergic targets for the treatment of alcohol use disorder. [europepmc]
• β-Adrenoceptors as drug targets in melanoma: novel preclinical evidence for a role of β 3 -adrenoceptors. [europepmc]
• GPCRomics: An Approach to Discover GPCR Drug Targets. [europepmc]
• Leveraging Signaling Pathways to Treat Heart Failure With Reduced Ejection Fraction. [europepmc]
• Autonomic regulation of T-lymphocytes: Implications in cardiovascular disease. [europepmc]
• Beta-blockers for suspected or diagnosed acute myocardial infarction. [europepmc]
• 100 years of modelling ligand-receptor binding and response: A focus on GPCRs. [europepmc]
• α 1 -Adrenergic Receptors in Neurotransmission, Synaptic Plasticity, and Cognition. [europepmc]
• ADAM17, A Key Player of Cardiac Inflammation and Fibrosis in Heart Failure Development During Chronic Catecholamine Stress. [europepmc]
• The Neuromodulatory Role of the Noradrenergic and Cholinergic Systems and Their Interplay in Cognitive Functions: A Focused Review. [europepmc]
• Silent pheochromocytoma and paraganglioma: Systematic review and proposed definitions for standardized terminology. [europepmc]
• α 1 -Adrenergic Receptors: Insights into Potential Therapeutic Opportunities for COVID-19, Heart Failure, and Alzheimer's Disease. [europepmc]
• G Protein-Coupled Receptors: A Century of Research and Discovery. [europepmc]
• How Does Physical Activity Modulate Hormone Responses? [europepmc]